Transmission Blockirg Immunity in Plasmodium vivax Malaria: Antibodies Raised against a Peptide Block Parasite Development in the Mosquito Vector

dc.contributor.authorSnewin, V A
dc.contributor.authorPremawansa, S
dc.contributor.authorKapilananda, G M
dc.contributor.authorRatnayaka, L
dc.contributor.authorUdagama, P V
dc.contributor.authorMattei, D M
dc.contributor.authorKhouri, E
dc.contributor.authorDel Giudice, G
dc.date.accessioned2021-05-23T12:39:35Z
dc.date.available2021-05-23T12:39:35Z
dc.date.issued1995
dc.description.abstractOne approach towards the development of a vaccin-e against mala-ria is to immunize against the parasite^sexual stages that mediate transmission of the parasite_frol man to mosquito. Anti Lodies against theie stages, ingested with the blood meal, inhibit the parasite dwelopmen-t in the mos[uito vector, co-nstitutlng "transmission blocking imm-unity." Most epitopes involved in transmission-blocking immunity depend on the tertiary conformational structure of surface antigens. However, o.r. of th. transmission-blocking monoclonal antibodies we have raised against Plasrnodiun uiuax rcacts with a linear epitope on both asexual stages and gametes' This monoclonal antibo dy (A12) is capable of totally blocking development -of the parasite in themosquito host when t.ri.d i., membiane feeding assays with gametocytes from P uiuax-infected patients. Immune screening of a P. uiuax \gt11-genomic expression library with A12 led to the isolation of a clone ro whi;h was mapped the si*amino acid epitope recognized by A12. Antisera raised in mice against a 72-mer synihetic peptide containing this epitope coupled to bovine serum albumin nJt only had higlr titers of antipeptide antibodies as measured by enzyme-linked immunosorbent assay, but in addition recognized the same 24- and 57-kD parasite comPonents as A12 on'Western blots and reacted wiih the parasite by immunofuorescence. When tested in membrane feeding assays, these antibodies have significant suPpressive effects on parasite development in the mosquito.en_US
dc.description.sponsorshipThis work was supported by the United Nations Development Programme/World Bank/World Health Organisation Special Programme for Research and Tlaining in Tiopical Disease (TDR), by the Rockefeller Foundation, the EEC programme for Life Science and tchnologies in Developing Countries (STD3), the Centre National de la Recherche Scientifique, the Pasteur Institute, and the "Ministdre de la Recherche et de l'Enseignement Sup6rieur".en_US
dc.identifier.citation30en_US
dc.identifier.otherhttps://doi.org/10.1084/jem.181.1.357
dc.identifier.urihttp://archive.cmb.ac.lk:8080/xmlui/handle/70130/5219
dc.language.isoenen_US
dc.publisherJournal of Experimental Medicineen_US
dc.subjectPlasmodium vivaxen_US
dc.subjectmosquito vectoren_US
dc.subjectantibodiesen_US
dc.subjectMalariaen_US
dc.titleTransmission Blockirg Immunity in Plasmodium vivax Malaria: Antibodies Raised against a Peptide Block Parasite Development in the Mosquito Vectoren_US
dc.typeArticleen_US

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
10.pdf
Size:
5.77 MB
Format:
Adobe Portable Document Format
Description:
Main article

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: